Document is current
Any future updates will be listed below
-
Authors
Zaharia, Oana P.
Kupriyanova, Yuliya
Karusheva, Yanislava
Markgraf, Daniel F.
Kantartzis, Konstantinos
Birkenfeld, Andreas L.
Trenell, Michael
Sahasranaman, Aarti
Cheyette, Chris
Kössler, Theresa
Bódis, Kálmán
Burkart, Volker
Hwang, Jong-Hee
Roden, Michael
Szendroedi, Julia https://orcid.org/0000-0002-5185-8168
Pesta, Dominik H.
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung
Deutsche Diabetes Gesellschaft
EIT Health
Deutsches Diabetes-Zentrum (DDZ)
- License Information
-
More Information
Article History
Received: 26 August 2020
Accepted: 16 February 2021
First Online: 11 April 2021
Compliance with ethical standards
:
: Michael Roden serves as investigator of studies supported by Boehringer-Ingelheim Pharma, Nutriticia / Danone and Sanofi and has served as advisor/consultant for Bristol-Myers Squibb, Eli Lilly, Gilead, Intercept Pharma, Novo Nordisk, Novartis, Poxel, Prosciento, Sanofi, Servier and TARGET NASH. Michael Trenell is co-founder of Changing Health Ltd, a spin-out company from Newcastle University and Newcastle upon Tyne NHS Hospitals Trust. Chris Cheyette authored the recipe book ‘Carbs & Cals’ and is managing director at Chello Publishing Limited.
: The study was approved by local institutional review boards (ethics boards Heinrich-Heine-University Düsseldorf, reference number 4508, amendment 20, and University Hospital Tübingen reference number 385/2018BO2), registered with clinical trials.gov NCT04509245 and was performed according to the Declaration of Helsinki. All persons gave their informed consent prior to their inclusion in the study.
